Drug Topics

MAY 15, 2023

Marketing costs money, so be sure to spend wisely.

Independent Pharmacies 187

Independent Pharmacies 187

Drug Topics

MAY 16, 2023

The National Community Pharmacists Association now has plenty of allies in its fight with the pharmacy benefit managers.

187

187

Pharmacy Times

MAY 17, 2023

Good practice for older adults is that calories should go down while nutrient intake goes up as they age.

123

123

PhRMA

MAY 16, 2023

Enhancing clinical trial diversity is a challenge, but with a multi-faceted, community-centered approach, we can help underrepresented patients be more involved in the research and development of potential life-saving medical treatments.

162

162

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Fierce Pharma

MAY 19, 2023

Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease zbecker Fri, 05/19/2023 - 16:25

FDA 145

FDA 145

Drug Topics

MAY 19, 2023

Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.

Vaccines 198

Vaccines 198

Pharmacy Times

MAY 19, 2023

Nanoparticles could improve the solubility of drugs, aid in treatment escape from the immune system, and increase the half-life of drugs in the circulatory system against viral lung infections such as influenza, coronavirus, and respiratory syncytial virus.

Immunization 139

Immunization Vaccines 139

Fierce Healthcare

MAY 16, 2023

Kaiser Permanente discloses timeline, financial commitments for its VBC megadeal with Geisinger Health dmuoio Tue, 05/16/2023 - 12:40

138

138

Drug Topics

MAY 19, 2023

Your weekly roundup of the latest news from Drug Topics®.

187

187

STAT

MAY 19, 2023

A defanged form of CRISPR, which doesn’t slice or nick DNA, but rather alters the epigenome — the layers of chemical coding that sit on top of DNA and control the activity of genes — has aced its first substantive test. When researchers used CRISPR “ epigenome editing ” to dial down a cholesterol-associated gene in monkeys, the animals’ blood levels of heart-disease-causing LDL, or “bad” cholesterol, plummeted by more than 50%, Jennifer Kwo

143

143

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MAY 15, 2023

Diagnosing risk of frailty in patients hospitalized with heart failure is a safe and effective means of improving patient management.

Hospitals 139

Hospitals 139

Fierce Healthcare

MAY 15, 2023

PBGH: What employers want to see as Congress aims to reform PBMs pminemyer Mon, 05/15/2023 - 16:13

138

138

Drug Topics

MAY 15, 2023

Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.

187

187

STAT

MAY 19, 2023

When cyclist Alison Tetrick joined the sport’s professional ranks, she received the perks that come with the job — new bikes and clothing included. But she could never get comfortable on the bike saddles. After several years, Tetrick suffered so much damage to her genital area that she eventually resorted to surgery to trim excess skin from her labia.

142

142

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 15, 2023

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Vaccines 139

Vaccines 139

Fierce Healthcare

MAY 19, 2023

Cybersecurity attack against Amazon-owned online pharmacy PillPack exposed user health data aburky Fri, 05/19/2023 - 16:16

137

137

Drug Topics

MAY 15, 2023

Doing small spurts of exercise throughout the day provide numerous benefits.

187

187

STAT

MAY 17, 2023

When someone has leprosy, people who live in the same household face the highest odds of contracting the infection. But in a new trial, providing those contacts with a single dose of an antibiotic typically used to treat tuberculosis drastically reduced that risk, researchers reported Wednesday. The trial, which took place in China, corroborates the idea of giving close contacts an antibiotic as a way to reduce the likelihood that the disease spreads, experts said.

141

141

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

MAY 19, 2023

Intercept's NASH dreams may be dashed after FDA panel votes against Ocaliva's approval bid fkansteiner Fri, 05/19/2023 - 17:30

FDA 134

FDA 134

Fierce Healthcare

MAY 17, 2023

FTC expands probe into pharmacy benefit managers to GPOs pminemyer Wed, 05/17/2023 - 16:36

135

135

Pharmaceutical Technology

MAY 19, 2023

The US Food and Drug Administration (FDA) has granted approval to Bausch + Lomb and Novaliq’s Miebo (perfluorohexyloctane ophthalmic solution) to treat the signs and symptoms of dry eye disease (DED). Formerly known as NOV03, Miebo is a first-in-class eye drop designed for preventing the evaporation of excessive tears and restoring tear balance in evaporative DED patients.

FDA 133

FDA Adverse Reactions 133

Pharmacy Times

MAY 19, 2023

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care.

132

132

Fierce Pharma

MAY 19, 2023

Bausch + Lomb bags FDA approval for dry eye disease treatment Miebo zbecker Fri, 05/19/2023 - 09:39

FDA 133

FDA 133

Fierce Healthcare

MAY 19, 2023

Commercial payers frequently delayed paying out providers' claims in Q1, report finds dmuoio Fri, 05/19/2023 - 15:44

133

133

STAT

MAY 19, 2023

Four different companies agreed to buy the assets of Pear Therapeutics at auction on Thursday morning after the digital health company filed for bankruptcy last month. Click Therapeutics, Welt Corp, Harvest Bio, and Nox Health Group each acquired bits of the company for $6.05 million, far short of the $32 million in debt Pear carried. A hearing to approve the sale will be held on May 22.

FDA 131

FDA 131

Pharmacy Times

MAY 19, 2023

The approval marks the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.

FDA 132

FDA 132

Fierce Pharma

MAY 17, 2023

Regulatory tracker: Another China-made PD-1 starts FDA journey as Elevar, Hengrui target big cancer type aliu Wed, 05/17/2023 - 09:41

FDA 132

FDA 132

Fierce Healthcare

MAY 14, 2023

Industry Voices—The case for hospitals to invest in cleaner air pminemyer Sun, 05/14/2023 - 23:25

Hospitals 131

Hospitals 131

STAT

MAY 16, 2023

WASHINGTON — The White House is summoning naloxone manufacturers for a roundtable focused on the medication’s price, the Biden administration’s top drug policy official told STAT. The move would represent the White House’s most concrete action to date to address the price of naloxone , a medication used to reverse opioid overdoses.

131

131

Pharmacy Times

MAY 15, 2023

Patients with HIV were no less likely to show a worse clinical presentation following tecovirimat treatment.

132

132

Fierce Pharma

MAY 15, 2023

Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?

131

131

PhRMA

MAY 15, 2023

To achieve a healthier world where all people have access to life-changing medicines, we must support researchers working to advance biopharmaceutical innovation and value-driven health care. This is the purpose of the PhRMA Foundation, a 58-year-old nonprofit that catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships.

130

130

IDStewardship

MAY 13, 2023

In this article an infectious diseases pharmacists discusses the MAD-ID conference, which is known as The Antimicrobial Stewardship Meeting, Making A Difference In Infectious Diseases (MAD-ID). Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 14 May 2023 People practicing in the area of infectious diseases and antimicrobial stewardship have a lot of options for professional meetings to attend.

Communication 130

Communication 130